The Yervoy monotherapy label on the FDA website has a qualifier not shown in your post: patients must have an annual income of at least $250,000 and net assets (excluding a primary residence) of at least $2M.
“The efficient-market hypothesis may be the foremost piece of B.S. ever promulgated in any area of human knowledge!”